These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33435823)

  • 1. Sensitivity and specificity of drug interaction databases to detect interactions with recently approved oral antineoplastics.
    Bossaer JB; Eskens D; Gardner A
    J Oncol Pharm Pract; 2022 Jan; 28(1):82-86. PubMed ID: 33435823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Interaction Database Sensitivity With Oral Antineoplastics: An Exploratory Analysis.
    Bossaer JB; Thomas CM
    J Oncol Pract; 2017 Mar; 13(3):e217-e222. PubMed ID: 28095171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective cohort observation on psychotropic drug-drug interaction and identification utility from 3 databases: Drugs.com®, Lexicomp®, and Epocrates®.
    Pinkoh R; Rodsiri R; Wainipitapong S
    PLoS One; 2023; 18(6):e0287575. PubMed ID: 37347788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Nine Tools for Screening Drug-Drug Interactions of Oral Oncolytics.
    Marcath LA; Xi J; Hoylman EK; Kidwell KM; Kraft SL; Hertz DL
    J Oncol Pract; 2018 Jun; 14(6):e368-e374. PubMed ID: 29787332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of potential drug-drug interactions with metabolic syndrome medications detected by two databases.
    Suriyapakorn B; Chairat P; Boonyoprakarn S; Rojanarattanangkul P; Pisetcheep W; Hunsakunachai N; Vivithanaporn P; Wongwiwatthananukit S; Khemawoot P
    PLoS One; 2019; 14(11):e0225239. PubMed ID: 31725785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electronic database to detect drug-drug interactions between antidepressants and oral anticancer drugs from a cancer center in Singapore: implications to clinicians.
    Chan A; Yap KY; Koh D; Low XH; Cheung YT;
    Pharmacoepidemiol Drug Saf; 2011 Sep; 20(9):939-47. PubMed ID: 21732473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of potential drug-drug interactions in patients with castration-resistant prostate cancer treated with abiraterone acetate.
    Jamani R; Lee EK; Berry SR; Saluja R; DeAngelis C; Giotis A; Emmenegger U
    Eur J Clin Pharmacol; 2016 Nov; 72(11):1391-1399. PubMed ID: 27561266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of drug-drug interactions in cancer patients treated at a university hospital in North Cyprus using two interaction databases.
    Laban AA; Birand N; Chukwunyere U; Abdi A; Basgut B
    Niger J Clin Pract; 2021 Jul; 24(7):1067-1071. PubMed ID: 34290184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials.
    Marcath LA; Coe TD; Hoylman EK; Redman BG; Hertz DL
    BMC Cancer; 2018 Nov; 18(1):1155. PubMed ID: 30466416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of five common drug-drug interaction software programs regarding accuracy and comprehensiveness.
    Kheshti R; Aalipour M; Namazi S
    J Res Pharm Pract; 2016; 5(4):257-263. PubMed ID: 27843962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world prevalence of potential drug-drug interactions involving oral antineoplastic agents: a population-based study.
    Kim SH; Suh Y; Ah YM; Jun K; Lee JY
    Support Care Cancer; 2020 Aug; 28(8):3617-3626. PubMed ID: 31802250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of potential drug-drug interactions in prescription orders dispensed in a community pharmacy setting using Micromedex
    Abbas A; Al-Shaibi S; Sankaralingam S; Awaisu A; Kattezhathu VS; Wongwiwatthananukit S; Owusu YB
    Int J Clin Pharm; 2022 Apr; 44(2):348-356. PubMed ID: 34811600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-drug interactions in pediatric oncology patients.
    Balk TE; van der Sijs IH; van Gelder T; Janssen JJB; van der Sluis IM; van Leeuwen RWF; Engels FK
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28205376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-life drug-drug and herb-drug interactions in outpatients taking oral anticancer drugs: comparison with databases.
    Prely H; Herledan C; Caffin AG; Baudouin A; Larbre V; Maire M; Schwiertz V; Vantard N; Ranchon F; Rioufol C
    J Cancer Res Clin Oncol; 2022 Mar; 148(3):707-718. PubMed ID: 33914124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: profiling and comparison of two drug compendia.
    Wong CM; Ko Y; Chan A
    Ann Pharmacother; 2008 Dec; 42(12):1737-48. PubMed ID: 19033481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective drug utilization review: incidence of clinically relevant potential drug-drug interactions in a large ambulatory population.
    Peng CC; Glassman PA; Marks IR; Fowler C; Castiglione B; Good CB
    J Manag Care Pharm; 2003; 9(6):513-22. PubMed ID: 14664659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two databases to detect potential drug-drug interactions between prescriptions of HIV/AIDS patients in critical care.
    Ramos GV; Guaraldo L; Japiassú AM; Bozza FA
    J Clin Pharm Ther; 2015 Feb; 40(1):63-7. PubMed ID: 25329640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of three drug-drug interaction screening systems against probable clinically relevant drug-drug interactions: a prospective cohort study.
    Muhič N; Mrhar A; Brvar M
    Eur J Clin Pharmacol; 2017 Jul; 73(7):875-882. PubMed ID: 28299402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Drug Interaction Adverse Events in Patients With COVID-19: A Systematic Review.
    Conti V; Sellitto C; Torsiello M; Manzo V; De Bellis E; Stefanelli B; Bertini N; Costantino M; Maci C; Raschi E; Sabbatino F; Corbi G; Pagliano P; Filippelli A
    JAMA Netw Open; 2022 Apr; 5(4):e227970. PubMed ID: 35438752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Systematic Review of Gastric Acid-Reducing Agent-Mediated Drug-Drug Interactions with Orally Administered Medications.
    Patel D; Bertz R; Ren S; Boulton DW; Någård M
    Clin Pharmacokinet; 2020 Apr; 59(4):447-462. PubMed ID: 31788764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.